The Global Zika Vaccines Market is expected to to be around US$ 22843 Million by 2028 at a CAGR of 5.2 %.
Zika virus is a rising viral illness that is transmitted through the bite of an infected mosquito, basically Aedes aegypti, a similar vector that transmits chikungunya, dengue and yellow fever. To treat the chronic health conditions occurring due to the Zika virus different novel approaches are being developed. Serious birth issues occur in Pregnant women and they are at high risk due to the connection of the zika virus. To overcome all this problem its essential to develop zika virus to prevent the complications of Zika virus infection in humans.
Different government and non-government bodies are taking different activities to create antibodies against the Zika virus. Growing population in zika affected individuals, growing awareness, increasing human trials and opportunities in the treatment and anticipation of the Zika virus additionally for counteractive action and vaccination, expanding advancement in healthcare division in different economies over the globe.
The global Zika Vaccines market is segregated on the basis of Type as Inactivated Vaccine, Purified Inactivated Vaccine, and DNA Vaccine. Based on Application the global Zika Vaccines market is segmented in Clinics, Academic and Research, Hospitals, and Others.
The global Zika Vaccines market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Zika Vaccines market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax, Gilead Sciences Inc., Intrexon Corp., NewLink Genetics Corp, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline, Takeda, and others are among the major players in the global Zika Vaccines market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Zika Vaccines Market has been segmented as below:
Zika Vaccines Market, By Type
Zika Vaccines Market, By Application
Zika Vaccines Market, By Region
Zika Vaccines Market, By Company
The report covers:
Report Scope:
The global Zika Vaccines market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Zika Vaccines market share. Major industry players with significant revenue share include Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax, Gilead Sciences Inc., Intrexon Corp., NewLink Genetics Corp, Hawaii Biotech Inc., Sanofi, GlaxoSmithKline, Takeda, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Wedge Pressure Catheter Market
Transabdominal Retrieval Kit Market
Automated Compounding System Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Zika Vaccines Market, By Type
5.1 Introduction
5.2 Inactivated Vaccine
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Purified Inactivated Vaccine
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 DNA Vaccine
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Zika Vaccines Market, By Application
6.1 Introduction
6.2 Clinics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Academic and Research
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Hospitals
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Others
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Zika Vaccines Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Zika Vaccines, By Type
7.2.2 North America Zika Vaccines, By Application
7.3 Europe
7.3.1 Europe Zika Vaccines, By Type
7.3.2 Europe Zika Vaccines, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Zika Vaccines, By Type
7.4.2 Asia-Pacific Zika Vaccines, By Application
7.5 Rest of the World
7.5.1 Rest of the World Zika Vaccines, By Type
7.5.2 Rest of the World Zika Vaccines, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Inovio Pharmaceuticals
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 GeneOne Life Science Inc
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 PaxVax
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Gilead Sciences Inc.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Intrexon Corp.
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 NewLink Genetics Corp
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Hawaii Biotech Inc.
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Sanofi
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 GlaxoSmithKline
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Takeda
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Zika Vaccines Market has been segmented as below:
Zika Vaccines Market, By Type
Zika Vaccines Market, By Application
Zika Vaccines Market, By Region
Zika Vaccines Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
